Notice Information
Notice Title
Electronic Quality Management System (eQMS) for Medicines Discovery Catapult
Notice Description
Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. MDC requires a robust Electronic Quality Management System (eQMS) to support business growth and new projects involving clinical samples. The new eQMS is required to provide full traceability for all activities pertaining to clinical samples, whilst also supporting MDC's operations at large. Further information can be found at https://procontract.due-north.com/RFx/RFxSummary?rfxId=532e9bbc-1846-ed11-811a-005056b64545&projectId=482d48e6-1046-ed11-811a-005056b64545
Lot Information
Lot 1
Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. MDC requires a robust eQMS to support business growth and new projects involving clinical samples. The new eQMS is required to provide full traceability for all activities pertaining to clinical samples, whilst also supporting MDC's operations at large. An open procurement procedure is being used. Further information can be found at https://procontract.due-north.com/RFx/RFxSummary?rfxId=532e9bbc-1846-ed11-811a-005056b64545&projectId=482d48e6-1046-ed11-811a-005056b64545
Renewal: This is an initial 3-year contract, with the option to extend for a further four separate 1-year periods subject to the awarded suppliers satisfactory performance.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-0373f4
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/028270-2022
- Current Stage
- Tender
- All Stages
- Tender
Procurement Classification
- Notice Type
- Tender Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
72 - IT services: consulting, software development, Internet and support
-
- CPV Codes
72000000 - IT services: consulting, software development, Internet and support
Notice Value(s)
- Tender Value
- £455,000 £100K-£500K
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 7 Oct 20223 years ago
- Submission Deadline
- 7 Nov 2022Expired
- Future Notice Date
- Not specified
- Award Date
- Not specified
- Contract Period
- 1 Jan 2023 - 31 Dec 2030 Over 5 years
- Recurrence
- Not specified
Notice Status
- Tender Status
- Active
- Lots Status
- Active
- Awards Status
- Not Specified
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- MEDICINES DISCOVERY CATAPULT
- Contact Name
- James Tomlinson
- Contact Email
- james.tomlinson@md.catapult.org.uk
- Contact Phone
- +44 1625708394
Buyer Location
- Locality
- CHESHIRE
- Postcode
- SK10 4ZF
- Post Town
- Stockport
- Country
- England
-
- Major Region (ITL 1)
- TLD North West (England)
- Basic Region (ITL 2)
- TLD6 Cheshire
- Small Region (ITL 3)
- TLD62 Cheshire East
- Delivery Location
- Not specified
-
- Local Authority
- Cheshire East
- Electoral Ward
- Chelford
- Westminster Constituency
- Tatton
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-0373f4-2022-10-07T14:30:44+01:00",
"date": "2022-10-07T14:30:44+01:00",
"ocid": "ocds-h6vhtk-0373f4",
"initiationType": "tender",
"tender": {
"id": "DN636698",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "Electronic Quality Management System (eQMS) for Medicines Discovery Catapult",
"status": "active",
"classification": {
"scheme": "CPV",
"id": "72000000",
"description": "IT services: consulting, software development, Internet and support"
},
"mainProcurementCategory": "services",
"description": "Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. MDC requires a robust Electronic Quality Management System (eQMS) to support business growth and new projects involving clinical samples. The new eQMS is required to provide full traceability for all activities pertaining to clinical samples, whilst also supporting MDC's operations at large. Further information can be found at https://procontract.due-north.com/RFx/RFxSummary?rfxId=532e9bbc-1846-ed11-811a-005056b64545&projectId=482d48e6-1046-ed11-811a-005056b64545",
"value": {
"amount": 455000,
"currency": "GBP"
},
"lots": [
{
"id": "1",
"description": "Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change. MDC requires a robust eQMS to support business growth and new projects involving clinical samples. The new eQMS is required to provide full traceability for all activities pertaining to clinical samples, whilst also supporting MDC's operations at large. An open procurement procedure is being used. Further information can be found at https://procontract.due-north.com/RFx/RFxSummary?rfxId=532e9bbc-1846-ed11-811a-005056b64545&projectId=482d48e6-1046-ed11-811a-005056b64545",
"contractPeriod": {
"startDate": "2023-01-01T00:00:00Z",
"endDate": "2030-12-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This is an initial 3-year contract, with the option to extend for a further four separate 1-year periods subject to the awarded suppliers satisfactory performance."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
}
],
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"region": "UK"
}
],
"relatedLot": "1"
}
],
"submissionMethod": [
"electronicSubmission"
],
"submissionMethodDetails": "https://procontract.due-north.com/RFx/RFxSummary?rfxId=532e9bbc-1846-ed11-811a-005056b64545&projectId=482d48e6-1046-ed11-811a-005056b64545",
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"coveredBy": [
"GPA"
],
"tenderPeriod": {
"endDate": "2022-11-07T15:00:00Z"
},
"submissionTerms": {
"languages": [
"en"
]
},
"awardPeriod": {
"startDate": "2022-11-07T15:00:00Z"
},
"bidOpening": {
"date": "2022-11-07T15:00:00Z"
},
"hasRecurrence": false
},
"parties": [
{
"id": "GB-FTS-23690",
"name": "Medicines Discovery Catapult",
"identifier": {
"legalName": "Medicines Discovery Catapult"
},
"address": {
"streetAddress": "Block 35, Mereside, Alderley Park",
"locality": "Cheshire",
"region": "UK",
"postalCode": "SK10 4ZF",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "James Tomlinson",
"telephone": "+44 1625708394",
"email": "james.tomlinson@md.catapult.org.uk",
"url": "https://procontract.due-north.com/RFx/RFxSummary?rfxId=532e9bbc-1846-ed11-811a-005056b64545&projectId=482d48e6-1046-ed11-811a-005056b64545"
},
"roles": [
"buyer"
],
"details": {
"url": "https://md.catapult.org.uk/",
"buyerProfile": "https://md.catapult.org.uk/",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"description": "Drug Discovery / Health"
}
]
}
},
{
"id": "GB-FTS-65453",
"name": "Medicines Discovery Catapult",
"identifier": {
"legalName": "Medicines Discovery Catapult"
},
"address": {
"streetAddress": "Block 35, Mereside, Alderley Park,",
"locality": "Cheshire",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
]
}
],
"buyer": {
"id": "GB-FTS-23690",
"name": "Medicines Discovery Catapult"
},
"language": "en"
}